DE MURO, Pierina
 Distribuzione geografica
Continente #
NA - Nord America 3.450
AS - Asia 2.359
EU - Europa 1.364
SA - Sud America 1.291
AF - Africa 85
Continente sconosciuto - Info sul continente non disponibili 9
OC - Oceania 7
Totale 8.565
Nazione #
US - Stati Uniti d'America 3.376
BR - Brasile 1.154
SG - Singapore 843
CN - Cina 841
UA - Ucraina 525
HK - Hong Kong 229
DE - Germania 192
FR - Francia 148
VN - Vietnam 145
IT - Italia 134
SE - Svezia 100
FI - Finlandia 87
GB - Regno Unito 76
TR - Turchia 59
AR - Argentina 51
CA - Canada 31
IQ - Iraq 31
ZA - Sudafrica 29
BD - Bangladesh 27
IN - India 26
MX - Messico 25
BE - Belgio 24
PK - Pakistan 24
VE - Venezuela 23
EC - Ecuador 21
KR - Corea 20
RU - Federazione Russa 18
UZ - Uzbekistan 18
MA - Marocco 17
JP - Giappone 16
PL - Polonia 14
ID - Indonesia 12
CL - Cile 10
CO - Colombia 9
KE - Kenya 9
AE - Emirati Arabi Uniti 8
DZ - Algeria 8
ES - Italia 8
EU - Europa 8
PE - Perù 8
PY - Paraguay 8
JO - Giordania 7
NP - Nepal 7
AU - Australia 6
IL - Israele 6
NL - Olanda 6
TN - Tunisia 6
DO - Repubblica Dominicana 5
EG - Egitto 5
LB - Libano 5
OM - Oman 5
PH - Filippine 5
AT - Austria 4
GR - Grecia 4
KZ - Kazakistan 4
AZ - Azerbaigian 3
BG - Bulgaria 3
BO - Bolivia 3
CR - Costa Rica 3
CZ - Repubblica Ceca 3
GE - Georgia 3
JM - Giamaica 3
LT - Lituania 3
SA - Arabia Saudita 3
UY - Uruguay 3
AL - Albania 2
CG - Congo 2
CH - Svizzera 2
CI - Costa d'Avorio 2
GT - Guatemala 2
HR - Croazia 2
KG - Kirghizistan 2
RS - Serbia 2
AM - Armenia 1
AO - Angola 1
BA - Bosnia-Erzegovina 1
BH - Bahrain 1
BS - Bahamas 1
BW - Botswana 1
BY - Bielorussia 1
ET - Etiopia 1
GA - Gabon 1
GY - Guiana 1
HN - Honduras 1
IE - Irlanda 1
IR - Iran 1
KN - Saint Kitts e Nevis 1
LA - Repubblica Popolare Democratica del Laos 1
LK - Sri Lanka 1
LU - Lussemburgo 1
MD - Moldavia 1
ML - Mali 1
MN - Mongolia 1
MR - Mauritania 1
MY - Malesia 1
NI - Nicaragua 1
NZ - Nuova Zelanda 1
PS - Palestinian Territory 1
RO - Romania 1
SI - Slovenia 1
Totale 8.560
Città #
Dallas 972
Singapore 482
Chandler 435
Jacksonville 316
Hong Kong 228
San Jose 184
Princeton 158
Ashburn 154
Nanjing 147
Beijing 145
Dearborn 104
São Paulo 87
New York 85
Ann Arbor 83
Wilmington 72
Lauterbourg 70
Nanchang 65
Sassari 59
Ho Chi Minh City 52
Shanghai 45
Boardman 43
Shenyang 43
Hebei 39
Rio de Janeiro 39
Los Angeles 33
Woodbridge 31
Belo Horizonte 30
Changsha 30
Tianjin 29
Hanoi 28
Ningbo 26
Santa Clara 26
Izmir 25
Brussels 24
Campinas 22
Mountain View 22
Hangzhou 21
Curitiba 20
Johannesburg 20
Seoul 20
Buffalo 19
Jinan 19
Orem 18
Zhengzhou 18
Jiaxing 17
Tashkent 17
Tokyo 15
Baghdad 14
Brasília 14
Kunming 14
Warsaw 14
Andover 13
Norwalk 13
San Francisco 13
Toronto 13
Goiânia 12
Columbus 11
London 11
Council Bluffs 10
Guangzhou 10
Guarulhos 10
Haiphong 10
Porto Alegre 10
Ribeirão Preto 10
Sorocaba 10
The Dalles 10
Betim 9
Brooklyn 9
Casablanca 9
Helsinki 9
Caxias do Sul 8
Chennai 8
Da Nang 8
Manaus 8
Manchester 8
Nairobi 8
Stockholm 8
São José dos Campos 8
Atlanta 7
Campo Grande 7
Denver 7
Fortaleza 7
Frankfurt am Main 7
Montreal 7
Osasco 7
Phoenix 7
Quito 7
Recife 7
Santo André 7
Villiers-sur-marne 7
Americana 6
Amman 6
Auburn Hills 6
Blumenau 6
Boston 6
Buenos Aires 6
Carapicuíba 6
Dhaka 6
Florianópolis 6
Franca 6
Totale 5.103
Nome #
Albumin-bound low molecular weight thiols analysis in plasma and carotid plaques by CE 201
Apolipoprotein Profiles in Atherosclerotic Disease 177
Identification of differentially expressed plasma proteins in atherosclerotic patients with type 2 diabetes 158
Apolipoprotein Profiles in Atherosclerotic Disease 153
Kidney post-transplant monitoring of urinary glycosaminoglycans/proteoglycans and monokine induced by IFN-g (MIG) 148
Human serum albumin Cys34 oxidative modifications following infiltration in the carotid atherosclerotic plaque 147
A longitudinal evaluation of urinary glycosaminoglycan excretion in normoalbuminuric type 1 diabetic patients 145
Evaluation of Early Markers of Nephropathy in Patients with Type 2 Diabetes Mellitus 143
Dna polymorphisms in north sardinian newborns and their linkage with abnormal globin gene arrangiements and with beta°-thalassemia 137
Polymorphism of foetal haemoglobin in the sardinian Beta+-Thalassaemia. 135
Evaluation of human serum albumin sulfhydryl groups oxidation in plasma and atherosclerotic plaque extracts 135
Evaluation of plasma glycosaminoglycans levels and structure in patients undergoing carotid endarterectomy 134
Buoyant density of Lp(a) subclasses in hypercholesterolemia 134
DNA polymorphisms in north-Sardinian newborns and their linkage with abnormal gamma globin gene arrangements and with B°-thalassemia 133
Evaluation of human serum albumin sulfhydryl groups oxidation in plasma and atherosclerotic plaque extracts 132
IDENTIFICATION OF POTENTIAL BIOMARKERS IN MYASTHENIA GRAVIS DISEASE BY PLASMA PROTEOMIC ANALYSIS 131
Levels of Urinary Trypsin Inhibitor and Structure of Its Chondroitin Sulphate Moiety in Type 1 and Type 2 Diabetes 130
Glycosaminoglycan and transforming growth factor beta 1 changes in human plasma and urine during the menstrual cycle, in vitro fertilization treatment, and pregnancy 130
Quali-quantitative analysis of urinary glycosaminoglycans for monitoring glomerular inflammatory activity 127
Plasma vitronectin is reduced in patients with myasthenia gravis: Diagnostic and pathophysiological potential 126
Development of a method for urine bikunin/urinary trypsin inhibitor (UTI) quantitation and structural characterization: Application to type 1 and type 2 diabetes 125
Kidney post-transplant monitoring of urinary glycosaminoglycans/proteoglycans and monokine induced by IFN-γ (MIG). 125
Characterization of glycosaminoglycans in human plasma from patients receiving haemodyalisis and their interaction with human LDL 123
Impact of first trimester fasting glycemic levels on expression of proteoglycans in pregnancy 121
Polymorphism of foetal haemoglobin in the Sardinian B+-thalassemia 121
Sulphated polysaccharide content and localization in some marine sponge species. 119
Characterization of a protein-glycosaminoglycan complex in urine from healthy subjects 119
Evaluation of plasma glycosaminoglycans levels and structure in patients undergoingcarotid endarterectomy 118
Urinary glycosaminoglycan and proteoglycan excretion in normoalbuminuric patients with type 1 diabetes mellitus 118
Urinary glycosaminoglycan composition in chronic glomerulonephritis 118
Significance of urinary glycosaminoglycans/proteoglycans in the evaluation of type 1 and type 2 diabetes complications 114
Proteomic analysis of plasma apolipoproteins in relation to atherosclerosis 114
Blood and urine glycosaminoglycan variations during different hypocholesterolemic therapies in type 2 diabetic patients 113
Hb G-Philadelphia, or [alpha68(E17)AsnLys], in North Sardinia: detection by isoelectric focusing and HPLC of tryptic peptides 108
Proteomic analysis of plasma-purified VLDL, LDL, and HDL fractions from atherosclerotic patients undergoing carotid endarterectomy: identification of Serum Amyloid A as a potential marker 108
QUANTITATIVE AND STRUCTURAL ANALYSES OF URINARY TRYPSIN INHIBITOR IN TYPE 1 AND TYPE 2 DIABETES 105
Plasma PP13, urinary GAGs/PGs as early markers of pre-eclampsia 105
DNA polymorphisms in North Sardinian newborns and their linkage with abnormal gamma globin gene arrangements and with betao-thalassemia. 105
Structural and functional modifications of human aorta proteoglycans in atherosclerosis 104
Glycosamynoglycan diversity in sponge extracellular matrix 104
Glycosaminoglycan and transforming growth factor beta1 changes in human plasma and urine during the menstrual cycle, in vitro fertilization treatment, and pregnancy. IF 2009: 3.970 JCR: Q1 103
Atherosclerotic modifications of human proteoglycans 101
Urine bikunin as a marker of renal impairment in Fabry's disease 101
Ruolo dei proteoglicani nella medicina della riproduzione 101
GAG and protein composition of GAG-protein complexes from normal human plasma 99
Preliminary investigations of LDL interactions with proteoglycans extracted from human aortic walls with different atherosclerotic lesions 99
Haematological and biosynthetic features of beta°-thalassemia with an associated alpha-thalassemia heterozygosity in Sardinia 98
Plasma GAG-protein complexes modify chemical and physical properties of human LDL 97
Urinary glycosaminoglycans in patients with systemic lupus erythematosus 96
Role of the small proteoglycan bikunin in human reproduction 96
Evidences that atherosclerotic lesion involves modifications of arterial wall proteoglycans, affecting their interactions with LDL 94
Urine Bikunin Quantitation and Structural Characterization in Type I and Type II Diabetes Patients 94
Urinary trypsin inhibitor is a marker of renal disease in Fabry’s patients. 93
Iloprost therapy acutely decreases oxidative stress in patients affected by systemic sclerosis 93
Urinary excretion of GAGs during hypocholesterolemic therapy 93
Diversità molecolare negli invertebrati marini: screening dei glicosaminoglicani in spugne del Mediterraneo occidentale 91
The gamma globin chain heterogeneity of the Sardinian newborn baby. Hemoglobin, 10:519-528, 1986. 90
Ldl interaction with proteoglycans isolated from human aortas with different atherosclerotic involvement 89
Protein sulfhydryl group oxidation and mixed-disulfide modifications in stable and unstable human carotid plaques 88
Plasma levels of C-reactive protein, leptin and glycosaminoglycans during spontaneous menstrual cycle: differences between ovulatory and anovulatory cycles 88
Proteoglicani e diabete gestazionale: dati preliminari 87
Urinary transaforming growth factor beta 1 in various types of nephropathy 85
Urinary transforming growth factor-beta 1 in various types of nephropathy 85
The gamma globin chain heterogeneity of the Sardinian newborn baby 84
Modification of low density lipoprotein induced by the interaction with standard GAGs 83
Kidney post-transplant monitoring of urinary glycosaminoglycans/proteoglycans and monokine induced by IFN-ϒ (MIG) 83
Urinary glycosaminoglycansin patients with systemic lupus erytematosus 82
Post-translational modifications of proteoglycans during the development of atherosclerotic lesion 80
Hematological and biosynthetic features of betao-thalassemia with an associated beta-thalassemia heterozygosity in Sardinia. 80
Glycosaminoglycan biodiversity in W-Mediterranean marine sponges. 79
Proteomic analysis of plasma-purified VLDL, LDL and HDL fractions from atherosclerotic patients undergoing carotid endarterectomy: identification of Serum Amyloid A as a potential marker 79
Glycosaminoglycans and fabry’s disease 77
Fine structure of glycosaminoglycans from fresh and decellularized porcine cardiac valves and pericardium 77
Investigations on PGs extracted from human aorta of different age and with different atherosclerotic lesions 73
Human LDL binding to plasma high charge glycosaminoglycan-protein complexes 73
Urinary trypsin inhibitor is a marker of renal disease in Fabry’s patients 72
Human serum albumin Cys34 oxidative modifications following infiltration in the carotid atherosclerotic plaque 69
Modifications of low density lipoprotein induced by the interaction with human plasma glycosaminoglycan-protein complexes 69
Glycosaminoglycan diversity in sponge extracellular matrix 68
Plasma Levels of C-Reactive Protein, Leptin and Glycosaminoglycans During Spontaneous Menstrual Cycle: Differences Between Ovulatory and Anovulatory Cycles 68
Totale 8.600
Categoria #
all - tutte 34.156
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 34.156


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021126 0 0 0 0 0 0 0 0 0 98 16 12
2021/2022396 62 3 0 11 6 2 24 26 46 25 39 152
2022/2023802 84 54 14 149 82 141 0 93 130 9 28 18
2023/2024227 45 19 7 4 48 50 1 11 0 1 23 18
2024/20252.307 18 17 128 30 110 48 192 368 827 403 108 58
2025/20262.786 119 774 351 376 264 204 356 98 150 94 0 0
Totale 8.600